Antibody-Drug Conjugates
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
250
NCT05652868
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 23, 2023
Completion: Dec 31, 2027
Loading map...